Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Dec 15 (Reuters) - Lunit Inc 328130.KQ: LUNIT ANNOUNCES COLLABORATION WITH DAIICHI SANKYO TO ADVANCE AI-DRIVEN BIOMARKER DISCOVERY AND TRANSLATIONAL ONCOLOGY RESEARCH Source text: ID:nPnbK6cXfa Further company coverage: 328130.KQ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lunit
See all newsBrief: Summit Therapeutics And Lunit Announce Agreement To Apply Ai-Powered Scope Io Platform For Tumor Microenvironment Analysis In Immuno-Oncology Development
Brief: Lunit Inc To Conduct Capital Increase Of 250 Billion Won
Brief: Lunit Announces Collaboration with Daiichi Sankyo on AI-Driven Biomarker Discovery
Brief: Lunit Inc - Awarded National Tender In France For Breast AI
Brief: Lunit Expands Partnership With Saudi Arabia's Largest Medical Group To Deploy Ai Chest X-Ray Solution